# Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

> **NCT00814645** · PHASE1 · COMPLETED · sponsor: **Aires Pharmaceuticals, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Sodium Nitrite Inhalation Solution
- **DRUG:** Placebo and AIR001 Inhalation Solution (Expansion arm)

## Key facts

- **NCT ID:** NCT00814645
- **Lead sponsor:** Aires Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814645, "Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00814645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*